316 related articles for article (PubMed ID: 37355450)
1. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
2. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
3. Advances and Challenges in Rational Drug Design for SLCs.
Garibsingh RA; Schlessinger A
Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
5. The Druggability of Solute Carriers.
Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
[TBL] [Abstract][Full Text] [Related]
6. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
7. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
8. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in ligands and chemical probes targeting solute carrier transporters.
Casiraghi A; Bensimon A; Superti-Furga G
Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
[TBL] [Abstract][Full Text] [Related]
10. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
11. Membrane transporters in cell physiology, cancer metabolism and drug response.
Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional annotation of solute carrier transporters: implication for drug discovery.
Dvorak V; Superti-Furga G
Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933
[TBL] [Abstract][Full Text] [Related]
13. Role of solute carrier transporters in regulating dendritic cell maturation and function.
Shao L; Yang M; Sun T; Xia H; Du D; Li X; Jie Z
Eur J Immunol; 2024 Feb; 54(2):e2350385. PubMed ID: 38073515
[TBL] [Abstract][Full Text] [Related]
14. The RESOLUTE consortium: unlocking SLC transporters for drug discovery.
Superti-Furga G; Lackner D; Wiedmer T; Ingles-Prieto A; Barbosa B; Girardi E; Goldmann U; Gürtl B; Klavins K; Klimek C; Lindinger S; Liñeiro-Retes E; Müller AC; Onstein S; Redinger G; Reil D; Sedlyarov V; Wolf G; Crawford M; Everley R; Hepworth D; Liu S; Noell S; Piotrowski M; Stanton R; Zhang H; Corallino S; Faedo A; Insidioso M; Maresca G; Redaelli L; Sassone F; Scarabottolo L; Stucchi M; Tarroni P; Tremolada S; Batoulis H; Becker A; Bender E; Chang YN; Ehrmann A; Müller-Fahrnow A; Pütter V; Zindel D; Hamilton B; Lenter M; Santacruz D; Viollet C; Whitehurst C; Johnsson K; Leippe P; Baumgarten B; Chang L; Ibig Y; Pfeifer M; Reinhardt J; Schönbett J; Selzer P; Seuwen K; Bettembourg C; Biton B; Czech J; de Foucauld H; Didier M; Licher T; Mikol V; Pommereau A; Puech F; Yaligara V; Edwards A; Bongers BJ; Heitman LH; IJzerman AP; Sijben HJ; van Westen GJP; Grixti J; Kell DB; Mughal F; Swainston N; Wright-Muelas M; Bohstedt T; Burgess-Brown N; Carpenter L; Dürr K; Hansen J; Scacioc A; Banci G; Colas C; Digles D; Ecker G; Füzi B; Gamsjäger V; Grandits M; Martini R; Troger F; Altermatt P; Doucerain C; Dürrenberger F; Manolova V; Steck AL; Sundström H; Wilhelm M; Steppan CM
Nat Rev Drug Discov; 2020 Jul; 19(7):429-430. PubMed ID: 32265506
[No Abstract] [Full Text] [Related]
15. Molecular modeling and ligand docking for solute carrier (SLC) transporters.
Schlessinger A; Khuri N; Giacomini KM; Sali A
Curr Top Med Chem; 2013; 13(7):843-56. PubMed ID: 23578028
[TBL] [Abstract][Full Text] [Related]
16. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies.
Raturi S; Li H; Chang YN; Scacioc A; Bohstedt T; Fernandez-Cid A; Evans A; Abrusci P; Balakrishnan A; Pascoa TC; He D; Chi G; Kaur Singh N; Ye M; Li A; Shrestha L; Wang D; Williams EP; Burgess-Brown NA; Dürr KL; Puetter V; Ingles-Prieto A; Sauer DB
J Vis Exp; 2023 Sep; (199):. PubMed ID: 37843272
[TBL] [Abstract][Full Text] [Related]
18. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.
Scalise M; Console L; Galluccio M; Pochini L; Tonazzi A; Giangregorio N; Indiveri C
SLAS Discov; 2019 Oct; 24(9):867-881. PubMed ID: 31251685
[TBL] [Abstract][Full Text] [Related]
19. Targeting solute carriers to modulate receptor-ligand interactions.
Sijben HJ; Superti-Furga G; IJzerman AP; Heitman LH
Trends Pharmacol Sci; 2022 May; 43(5):358-361. PubMed ID: 35232590
[TBL] [Abstract][Full Text] [Related]
20. Classification Systems of Secondary Active Transporters.
Perland E; Fredriksson R
Trends Pharmacol Sci; 2017 Mar; 38(3):305-315. PubMed ID: 27939446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
